Related Experiment Video
Updated: Jul 14, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
End-stage renal disease due to polyomavirus in a cardiac transplant patient
Supriya Maddirala1, Jan V Pitha, Benjamin D Cowley
1Division of Nephrology and Hypertension, University of Florida Jacksonville, Shands Jacksonville, Jacksonville, FL 32209, USA. supriya.maddirala@jax.ufl.edu
Background:
A 51-year-old male orthotopic cardiac transplant recipient experienced a prolonged rejection episode immediately after transplantation. Three years and 5 months after transplantation, he presented with lower extremity swelling; at this presentation, the patient's serum creatinine level was 345 micromol/l (3.9 mg/dl), his urinalysis was trace positive for both protein and blood, the urinary sediment had no casts and his 24-hour urine collection showed 750 mg protein. The patient's renal function deteriorated over the next month, with his serum creatinine level reaching a peak of 530 micromol/l (6 mg/dl). He died 4 years and 3 months after transplantation as a result of an arrhythmia.
Investigations:
Physical examination, urine and blood analyses, ultrasound-guided renal biopsy and autopsy.
Diagnosis:
Polyomavirus-associated nephropathy with the development of end-stage renal disease.
Management:
Adjustment of immunosuppressive therapy and initiation of hemodialysis.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...